Fig. 1
From: Aspartate β-hydroxylase as a target for cancer therapy
ASPH catalytic reaction. Aspartyl and asparaginyl residues in cbEGF-like domains are hydroxylated
Fig. 1 | Journal of Experimental & Clinical Cancer Research
From: Aspartate β-hydroxylase as a target for cancer therapy
ASPH catalytic reaction. Aspartyl and asparaginyl residues in cbEGF-like domains are hydroxylated